These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15864911)

  • 1. On the road to the optimal treatment of lupus nephritis: are we there yet?
    Illei GG
    Lupus; 2005; 14(4):263-4. PubMed ID: 15864911
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of proliferative lupus nephritis: a changing landscape.
    Adu D
    Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lupus nephritis--a work in progress.
    Falk RJ
    N Engl J Med; 2000 Oct; 343(16):1182-3. PubMed ID: 11036127
    [No Abstract]   [Full Text] [Related]  

  • 5. How did cyclophosphamide become the drug of choice for lupus nephritis?
    Bargman JM
    Nephrol Dial Transplant; 2009 Feb; 24(2):381-4. PubMed ID: 19056783
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive therapy in lupus nephritis.
    D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lupus nephritis: art or science?
    Endre Z
    Intern Med J; 2001 Jul; 31(5):264-6. PubMed ID: 11512596
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.
    Chan TM; Tse KC; Tang CS; Lai KN; Li FK
    Lupus; 2005; 14(4):265-72. PubMed ID: 15864912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of immunosuppressive drugs in lupus nephritis].
    Klippel JH; Austin HA; Balow JE
    Ter Arkh; 1986; 58(7):109-11. PubMed ID: 2945277
    [No Abstract]   [Full Text] [Related]  

  • 13. Maintenance therapy for lupus nephritis--something old, something new.
    Balow JE; Austin HA
    N Engl J Med; 2004 Mar; 350(10):1044-6. PubMed ID: 14999117
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis.
    El-Sehemy MS; Al-Saaran AM; Baddour NM; Adam AG; Moez PE
    Egypt J Immunol; 2006; 13(1):39-52. PubMed ID: 17974149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of diffuse proliferative lupus nephritis: an Indian experience.
    Abraham MA; Korula A; Arun KN; Jayakrishnan K; John GT; Thomas PP; Jacob CK
    Natl Med J India; 1997; 10(6):273-5. PubMed ID: 9481097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclophosphamide or azathioprine on urinary podocytes in patients with diffuse proliferative lupus nephritis.
    Nakamura T; Ushiyama C; Shimada N; Sekizuka K; Ebihara I; Hara M; Koide H
    Nephron; 2001 Feb; 87(2):192-3. PubMed ID: 11244319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mycophenolate mofetil in lupus nephritis treatment].
    Savio V; Alba P; Babini AM
    Rev Fac Cien Med Univ Nac Cordoba; 2012; 69(4):219-23. PubMed ID: 23751789
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic factors of diffuse proliferative lupus nephritis.
    Lim CS; Chin HJ; Jung YC; Kim YS; Ahn C; Han JS; Kim S; Lee JS
    Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcome of lupus nephritis at the turn of the millennium.
    Uppal SS
    J Assoc Physicians India; 1999 Sep; 47(9):857-61. PubMed ID: 10778651
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide for severe lupus nephritis: where are we now?
    Mok CC
    Arthritis Rheum; 2004 Dec; 50(12):3748-50. PubMed ID: 15593210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.